|
|
||||||||
ORIGINAL RESEARCH |
From the Departments of Pathological Biochemistry, Obstetrics, Haematology, and Nutrition, Glasgow Royal Infirmary University National Health Service Trust, Glasgow, Scotland, United Kingdom.
Address reprint requests to: Naveed Sattar, MRCPath University Department of Pathological Biochemistry Glasgow Royal Infirmary University NHS Trust Glasgow, Scotland G31 2ER United Kingdom E-mail: nsattar{at}clinmed.gla.ac.uk
Objective: To assess whether waist circumference at the first antenatal visit predicts risk of developing hypertension later in pregnancy.
Methods: Pregnant women with singleton pregnancies (n = 1142, median age 29 years, interquartile range 2532 years, 387 primigravidas) were recruited at their first antenatal visits. Using standardized methods, midwives determined the weights, heights (for calculation of body mass index [BMI]), and waist circumferences of all women. Eighty-two women developed pregnancy-induced hypertension, and 21 developed preeclampsia (hypertension with proteinuria).
Results: The median waist circumference between 6 and 16 weeks gestation was 79 cm (interquartile range 7284 cm), and there was no significant relationship between waist circumference and gestational age. Greater waist circumference was noted in subjects who subsequently developed pregnancy-induced hypertension (median 81 versus 77 cm, Mann-Whitney U test, P = .002) or preeclampsia (median 80 versus 77 cm, P = .02). The conventional, nonpregnant waist circumference action level of 80 cm gave a Mantel-Haenszel odds ratio (OR) for pregnancy-induced hypertension of 1.8 (95% confidence interval [CI] 1.1, 2.9) and for preeclampsia of 2.7 (95% CI 1.1, 6.8), compared with waists of less than 80 cm. Body mass index values were higher in women who developed pregnancy-induced hypertension (median 26 versus 24, P = .001) or preeclampsia (median 26 versus 24, P = .02). The conventional action limit for a BMI of 25 had an OR for pregnancy-induced hypertension of 2.0 (95% CI 1.2, 3.4) and for preeclampsia of 1.9 (95% CI 0.7, 4.8). Results were similar when the analysis was restricted to data from primigravidas.
Conclusion: We conclude that waist circumference up to 16 weeks gestation can predict pregnancy-induced hypertension and preeclampsia. Therefore, waist circumference could form the basis for health promotion involving raising awareness of the importance of or urging weight reduction for women planning pregnancies.
This article has been cited by other articles:
![]() |
B. Luke and M. B. Brown Elevated risks of pregnancy complications and adverse outcomes with increasing maternal age Hum. Reprod., May 1, 2007; 22(5): 1264 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Duckitt and D. Harrington Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies BMJ, March 12, 2005; 330(7491): 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Freeman, F. McManus, E. A. Brown, L. Cherry, J. Norrie, J. E. Ramsay, P. Clark, I. D. Walker, N. Sattar, and I. A. Greer Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia Hypertension, November 1, 2004; 44(5): 708 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ramsay, N. Jamieson, I. A. Greer, and N. Sattar Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia Hypertension, November 1, 2003; 42(5): 891 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Seely and C. G. Solomon Insulin Resistance and Its Potential Role in Pregnancy-Induced Hypertension J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2393 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wolf, L. Sandler, R. Jimenez-Kimble, A. Shah, J. L. Ecker, and R. Thadhani Insulin Resistance But Not Inflammation Is Associated With Gestational Hypertension Hypertension, December 1, 2002; 40(6): 886 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ramsay, W. R. Ferrell, L. Crawford, A. M. Wallace, I. A. Greer, and N. Sattar Maternal Obesity Is Associated with Dysregulation of Metabolic, Vascular, and Inflammatory Pathways J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4231 - 4237. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |